Rapid Dose Therapeutics Corp. (RDTCF)
OTCMKTS · Delayed Price · Currency is USD
0.1393
-0.0407 (-22.61%)
At close: Apr 8, 2025
Rapid Dose Therapeutics Balance Sheet
Financials in millions CAD. Fiscal year is March - February.
Millions CAD. Fiscal year is Mar - Feb.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | 2018 - 2020 |
Cash & Equivalents | 0.02 | 0.16 | 0.03 | 0.03 | 0.07 | Upgrade |
Cash & Short-Term Investments | 0.02 | 0.16 | 0.03 | 0.03 | 0.07 | Upgrade |
Cash Growth | -87.14% | 483.82% | -19.90% | -50.98% | 1925.42% | Upgrade |
Accounts Receivable | 0.14 | 0.03 | 0.06 | 0.07 | 0.08 | Upgrade |
Other Receivables | 0.16 | 0.19 | 0.09 | 0.11 | 0.17 | Upgrade |
Receivables | 0.3 | 0.22 | 0.15 | 0.18 | 0.26 | Upgrade |
Inventory | 0.26 | 0.17 | 0.16 | 0.28 | 0.37 | Upgrade |
Prepaid Expenses | 0.06 | 0.1 | 0.06 | 0.09 | 0.1 | Upgrade |
Other Current Assets | 0.03 | 0.03 | 0.03 | 0.03 | - | Upgrade |
Total Current Assets | 0.66 | 0.68 | 0.42 | 0.61 | 0.8 | Upgrade |
Property, Plant & Equipment | 0.97 | 1.21 | 1.83 | 2.45 | 3.03 | Upgrade |
Total Assets | 1.63 | 1.89 | 2.25 | 3.07 | 3.83 | Upgrade |
Accounts Payable | 1.94 | 1.12 | 2.78 | 1.36 | 1.83 | Upgrade |
Accrued Expenses | 2.29 | 1.47 | - | - | - | Upgrade |
Short-Term Debt | 2.61 | 0.21 | 1.57 | 0.76 | 1.23 | Upgrade |
Current Portion of Long-Term Debt | - | 0.09 | 0.19 | - | - | Upgrade |
Current Portion of Leases | - | 0.03 | 0.34 | 0.31 | 0.29 | Upgrade |
Current Unearned Revenue | - | - | 0.01 | 0.02 | 0.9 | Upgrade |
Total Current Liabilities | 6.84 | 2.92 | 4.89 | 2.45 | 4.25 | Upgrade |
Long-Term Debt | - | 2.12 | - | - | - | Upgrade |
Long-Term Leases | - | - | 0.03 | 0.36 | 0.67 | Upgrade |
Total Liabilities | 6.84 | 5.04 | 4.92 | 2.82 | 4.92 | Upgrade |
Common Stock | 28.26 | 26.61 | 25.13 | 25 | 18.6 | Upgrade |
Additional Paid-In Capital | 6.65 | 5.24 | 4.85 | 4.15 | 2.64 | Upgrade |
Retained Earnings | -44.6 | -39.26 | -34.97 | -31.16 | -22.67 | Upgrade |
Comprehensive Income & Other | 4.49 | 4.24 | 2.32 | 2.26 | 0.34 | Upgrade |
Shareholders' Equity | -5.21 | -3.16 | -2.67 | 0.25 | -1.09 | Upgrade |
Total Liabilities & Equity | 1.63 | 1.89 | 2.25 | 3.07 | 3.83 | Upgrade |
Total Debt | 2.61 | 2.45 | 2.12 | 1.43 | 2.19 | Upgrade |
Net Cash (Debt) | -2.59 | -2.29 | -2.1 | -1.4 | -2.12 | Upgrade |
Net Cash Per Share | -0.02 | -0.02 | -0.02 | -0.01 | -0.03 | Upgrade |
Filing Date Shares Outstanding | 129.53 | 122.3 | 103.57 | 103.07 | 80.67 | Upgrade |
Total Common Shares Outstanding | 129.53 | 117.81 | 103.57 | 103.07 | 80.67 | Upgrade |
Working Capital | -6.18 | -2.24 | -4.47 | -1.84 | -3.45 | Upgrade |
Book Value Per Share | -0.04 | -0.03 | -0.03 | 0.00 | -0.01 | Upgrade |
Tangible Book Value | -5.21 | -3.16 | -2.67 | 0.25 | -1.09 | Upgrade |
Tangible Book Value Per Share | -0.04 | -0.03 | -0.03 | 0.00 | -0.01 | Upgrade |
Machinery | 2.4 | 2.39 | 2.39 | 2.39 | 2.21 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.